SULTANID [Ampicillin + Sulbactam] 500 +250 mg Powder for solution for I\M administration
instructions for the medical use of
the medicinal product
SULTANID
Tradename
Sultanid, Султанид
International non-proprietary name
or generic name
Ampicillin + Sulbactam,
Ампициллин + Сульбактам
Composition
Sultanid 750 mg
Each vial contains: ampicillin
sodium equiv. ampicillin 500 mg,
sulbactam sodium equiv. sulbactam
250 mg.
The solvent ampoule contains:
lidocaine hydrochloride 1% 5 ml.
Sultanid 1500 mg
Each vial contains: ampicillin
sodium equiv. ampicillin 1000 mg,
sulbactam sodium equiv. sulbactam
500 mg.
The solvent ampoule contains:
lidocaine hydrochloride 1% 5 ml.
Dosage form
Powder for solution for
intramuscular injection.
Pharmacotherapeutic group
Antibiotic, penicillin semi-synthetic + beta-lactamase
inhibitor.
Pharmacological
properties
Combined broad-spectrum
antibacterial agent.
Pharmacodynamics
Ampicillin is an antibiotic from the
group of semi-synthetic penicillins, the bactericidal effect of which is
associated with inhibition of the synthesis of proteins in the cell wall of
microorganisms.
Sulbactam is an irreversible
beta-lactamase inhibitor. Expands the spectrum of activity of ampicillin
against resistant strains, the resistance of which develops under the influence
of beta-lactamase. Does not change the activity of ampicillin against
susceptible strains. By binding to some penicillin-binding proteins of
bacteria, it shows synergism when used simultaneously with beta-lactam
antibiotics. It is stable in aqueous solution, has independent antibacterial
activity against the Neisseriaceae and Acinetobacter spp. families, and is resistant
to most plasmid beta-lactamases.
The combination of
ampicillin+sulbacts is active in relation to aerobic gram-positive
bacteria-Staphylococcus aureus (stamps that produce and non-disclosure
beta-lactamase), staphylococcus epidermidis (strains producing and
non-converting beta-lactamase), Stap Hylococcus saprophyticus , Streptococcus
pyogenes, Streptococcus pneumoniae (including strains resistant to penicillin),
Streptococcus spp. groups viridans, Enterococcus faecalis, Listeria
monocytogenes; aerobic gram-negative bacteria - Escherichia coli, Proteus
mirabilis, Proteus vulgaris, Klebsiella spp., Neisseria gonorrhoeae
(beta-lactamase producing and non-producing strains), Moraxella catarrhalis
(beta-lactamase producing and non-producing strains), Morganella morganii,
Haemophilus influenzae (in including strains resistant to ampicillin),
Providencia rettgeri, Providencia stuartii; anaerobic microorganisms -
Bacteroides spp., including Bacteroides fragilis, Clostridium spp. (except
Clostridium difficile), Peptococcus spp., Peptostreptococcus spp.
Resistant: methicillin-resistant
Staphylococcus spp., Citrobacter spp., most strains of Enterobacter spp.,
Pseudomonas aeruginosa, Mycobacterium spp., Clostridium difficile, Chlamydia
pneumoniae, Mycoplasma pneumoniae.
Pharmacokinetics
Penetrates into most tissues and body fluids.
With inflammation, the permeability to the cerebrospinal fluid increases
dramatically.
After i / m administration, high concentrations
of ampicillin and sulbactam in the blood are achieved.
T1 / 2 - 1 h (for ampicillin and sulbactam).
Excreted by the kidneys - 70-80%, mainly unchanged, as well as with bile and
breast milk.
Sulbactam almost does not undergo metabolic
transformations and is excreted by the kidneys, mainly in an unchanged state
and only about 25% - in the form of metabolites.
Indications for use
Treatment of infectious and inflammatory
diseases caused by susceptible pathogens: respiratory infections (including
pneumonia, lung abscess, chronic bronchitis, pleural empyema); infections of
ENT organs (including sinusitis, tonsillitis, otitis media); infections of the
urinary tract and genital organs (pyelonephritis, pyelitis, cystitis, urethritis,
prostatitis, endometritis); biliary tract infections (cholecystitis,
cholangitis); infections of the skin and soft tissues (erysipelas, impetigo,
secondarily infected dermatitis); gastrointestinal infections (dysentery,
salmonellosis, salmonellosis); bone and joint infections; septic endocarditis;
meningitis; sepsis; peritonitis; scarlet fever; gonococcal infection.
Prevention of postoperative complications during
operations on the organs of the abdominal cavity and small pelvis.
Contraindications
Hypersensitivity to any of the components of the drug
and other beta-lactam antibiotics; infectious mononucleosis (including with the
appearance of a measles-like rash), lymphocytic leukemia.
When using lidocaine as a solvent - hypersensitivity
to local anesthetics of the amide type, severe shock, blockade of intracardiac
conduction, severe heart failure.
Method of administration and dosage
Sultanide is
administered intramuscularly.
Standard dosing regimen
Adults:
with a mild course of infection -1.5-3 g / day in 2 injections; with a moderate
course of infection - 3-6 g / day in 3-4 injections; in severe infections - 12
g / day in 3-4 injections.
Children: at the
rate of 150 mg/kg of body weight per day (corresponding to 100 mg/kg/day of
ampicillin and 50 mg/kg/day of sulbactam); frequency of administration - 3-4
times a day.
Newborns under
the age of 1 week and premature babies - at the rate of 75 mg / kg of body
weight per day with an interval of 12 hours.
Children weighing
40 kg or more should be dosed as recommended for adults, and the total dose of
sulbactam should not exceed 4 g per day.
Use in patients with impaired renal function
(creatinine clearance equal to or less than 30 ml / min)
|
Creatinine
clearance (ml/min/1,73
m2) |
Recommended
dosing regimen of Sultanid |
|
≥30 |
1,5-3 g with
an interval of 6-8 hours |
|
15-29 |
1,5-3 g at
intervals of 12 hours |
|
5-14 |
1,5-3 g at
intervals of 24 hours |
The maximum daily
dose is 12 g. The course of treatment is 5-14 days (with severe processes, the
treatment period can be extended). After the temperature normalizes and other
pathological symptoms disappear, treatment is continued for another 48 hours.
Dosing in special
cases
Uncomplicated gonorrhea
– 1,5 g once.
Prevention of
postoperative infections – 1,5-3 g, depending on the degree of infectious risk,
during anesthesia; then within 24 hours after surgery - at the same dose every
6-8 hours.
Preparation of
solutions
To the contents of the 750 mg or 1500 mg vial, add 2 ml or 4 ml of a 1%
lidocaine hydrochloride solution, respectively.
When treating children under the age of 1 year, do not dissolve the
drug in a solution of lidocaine hydrochloride. Water for injection can be used
as a solvent.
The drug diluted with lidocaine hydrochloride should not be
administered intravenously.
Special instructions and precautions
Before
using the drug, consult a doctor.
In patients with hypersensitivity to penicillins,
cross-allergic reactions with cephalosporin antibiotics are possible.
During the course of treatment, it is necessary to
monitor the state of the function of the hematopoietic organs, liver and
kidneys.
Perhaps the development of superinfection due to the
growth of microflora insensitive to the drug, which requires a corresponding
change in antibiotic therapy.
In the treatment of patients with sepsis, the
development of a bacteriolysis reaction (the Jarisch-Herxheimer reaction) is
possible.
With prolonged use of the drug, it is necessary to
periodically monitor the functions of the kidneys, liver and complete blood
count.
Before starting therapy, a thorough history should
be taken for previous allergic reactions to beta-lactam antibiotics. With the
development of an allergic reaction, the drug should be immediately discontinued.
When using the drug, both against the background of
taking it and 2-3 weeks after stopping treatment, diarrhea caused by
Clostridium difficile (pseudomembranous colitis) may develop. In mild cases, it
is sufficient to cancel treatment and use ion-exchange resins (colestyramine,
colestipol), in severe cases, compensation for the loss of fluid, electrolytes
and protein, the appointment of vancomycin or metronidazole is indicated. Do
not use drugs that inhibit intestinal motility.
When using ampicillin + sulbactam (as well as other
antibiotics), superinfection may develop, which requires discontinuation of the
drug and the appointment of appropriate treatment.
It is possible to detect a false positive Coombs
test, a false positive test for glucose in the urine (using the Benedict or
Fehling method).
In the treatment of patients with sepsis, the
development of a bacteriolysis reaction (Yarish Herxheimer reaction) is
possible.
Prescribe with caution: bronchial asthma, pollinosis
and other allergic diseases, liver failure, chronic diseases of the
gastrointestinal tract in history, previously transferred colitis associated
with the use of antibacterial drugs, impaired renal function, old age.
Influence on the ability to
drive vehicles and mechanisms
Given the likelihood of side effects from the central nervous system,
care should be taken when engaging in potentially hazardous activities that
require increased concentration and speed of psychomotor reactions.
Use
during pregnancy or lactation
Use during pregnancy is possible only if the intended benefit to the mother
outweighs the potential risk to the fetus.
Use during lactation (breastfeeding) is contraindicated.
Interaction with
other medicinal products
When
used simultaneously with indirect anticoagulants, ampicillin + sulbactam
potentiates their action; reduces the effectiveness of oral contraceptives,
drugs, during the metabolism of which para-aminobenzoic acid and ethinyl
estradiol are formed (risk of "breakthrough" bleeding).
With
simultaneous use with aminoglycosides, a pronounced synergism of bactericidal
action against gram-positive and gram-negative bacteria is observed.
Pharmaceutically
incompatible with blood products or protein hydrolysates, aminoglycosides. With
simultaneous use of the drug with aminoglycosides, drugs should not be mixed in
one syringe or one infusion system; when administered intramuscularly, inject
into different parts of the body.
Probenecid,
allopurinol, phenylbutazone, non-steroidal anti-inflammatory drugs reduce the
tubular secretion of ampicillin and sulbactam and increase their half-life.
Diuretics
reduce the clearance of penicillins.
Bactericidal
antibiotics (including cephalosporins, cycloserine, vancomycin, rifampicin,
aminoglycosides) have a synergistic effect; bacteriostatic antibiotics
(including macrolides, chloramphenicol, lincosamides, tetracyclines) -
antagonistic.
The
simultaneous use of ampicillin and allopurinol increases the risk of skin rash.
Side effect
From the digestive system: nausea, vomiting, loss of
appetite, diarrhea, increased activity of "liver" transaminases,
pseudomembranous enterocolitis.
On the part of the hematopoietic organs: hemolytic anemia, decreased
hemoglobin, thrombocytopenia, eosinophilia, leukopenia, neutropenia,
lymphopenia, lymphocytosis, thrombocytosis, monocytosis, false positive Coombs
test.
From the nervous system: drowsiness, malaise,
headache.
Laboratory indicators: azotemia, increased plasma
urea concentration, hypercreatininemia, decreased serum protein content,
leukocyturia, cylindruria.
Allergic reactions: urticaria, skin flushing,
pruritus, angioedema, rhinitis, conjunctivitis, fever, arthralgia, anaphylactic
shock, Stevens-Johnson syndrome, erythema multiforme exudative.
Local reactions: with I/M administration -
soreness at the injection site.
Other: malaise, chest pain, sore throat, dysuria, edema,
bleeding, with long-term treatment - candidiasis, the development of
superinfection.
If any of the side effects listed in the instructions
get worse, or if you notice any other side effects not listed in the
instructions, tell your doctor.
Symptoms:
nausea, vomiting, diarrhea, fluid and
electrolyte imbalance (as a result of vomiting and diarrhea), neurological
disorders up to seizures (especially in patients with impaired renal function).
Treatment:
symptomatic therapy, in severe cases -
hemodialysis.
Storage conditions
Store at a temperature not exceeding 30°C.
Keep out of the reach of children!
Shelf life
3 years. Do not use after the expiry date stated on
the packaging.
Vacation conditions
Dispensed by prescription.
Release form
Sultanid 750 mg
1 bottle
with powder for solution preparation and 1 ampoule with solvent together with instructions
for use in a cardboard box.
Sultanid 1500 mg
1 bottle with powder for solution preparation and 1 ampoule with solvent together with instructions for use in a cardboard box.
